MEF2C and neoplasm: The low expression of MEF2C in the exosomes of cancer tissues will cause the reduction of CD4 + T cells and macrophage levels in the tumor microenvironment, further affecting the prognosis of CRC tumors and T, M, N, and stage, leading to accelerated cancer development and metastasis.